Macro Finance
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Bloomberg Markets·September 24, 2026·1 min read
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range. The strong debut signals investor appetite for biotech IPOs, with the company securing substantial capital to advance its pipeline.
Read at Bloomberg MarketsDaily crypto arcade
Read the news, then play it.
Chainshorts turns crypto headlines into a daily game. Catch up in 60 words, then jump into daily lucky draws for a shot at the pot.